Company news

Acrux Limited news in 2023

Acrux Limited's news releases, calls and decks from 2023, newest first.

View company

Address of Chair and CEO to AGM

November 28, 2023

Acrux receives $2.88m R&D Tax Incentive Rebate for FY23

November 7, 2023

Investor Presentation - Acrux FY23 Results

August 24, 2023

Appendix 4E and FY23 Annual Report

August 24, 2023

Activities Statement and Appendix 4C

July 26, 2023

Acruxs seventh generic dossier accepted by FDA for review

July 3, 2023

4th FDA ANDA approval received - Dapsone Gel, 5%

June 7, 2023

Appendix 4D and Half Year Report

February 23, 2023

Quarterly Activities / Appendix 4C Cashflow Report

January 29, 2023

Gedeon Richter buyout Lenzetto Royalties for EUR4.1million

January 22, 2023

Decks in 2023